Showing results (1-10 of 241) with videos related to
Sort By:
Pageof 25
Circulation|March 15, 1996
C-type natriuretic peptide. An endogenous inhibitor of vascular angiotensin-converting enzyme activityN C Davidson, C S Barr, A D StruthersHeart (British Cardiac Society)|June 1, 1996
Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failureN C Davidson, W J Coutie, D J Webb, et al.European Heart Journal|December 24, 1997
Right coronary artery stenosis is associated with impaired cardiac endocrine function during exerciseN C Davidson, S D Pringle, T H Pringle, et al.Vascular Medicine (London, England)|January 1, 1997
Cutaneous vascular responses to acetylcholine are mediated by a prostanoid-dependent mechanism in manF Khan, N C Davidson, R C Littleford, et al.The American Journal of Cardiology|April 15, 1996
Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunctionN C Davidson, A A Naas, J K Hanson, et al.Heart (British Cardiac Society)|December 13, 2005
Angiotensin blockade or aldosterone blockade as the third neuroendocrine-blocking drug in mild but symptomatic heart failure patientsA D StruthersEuropean Heart Journal|December 24, 1997
Rationalizing the heart failure trials: from theory to practiceA D StruthersHeart (British Cardiac Society)|April 16, 2005
Pathophysiology of heart failure following myocardial infarctionA D StruthersCardiology|January 1, 1996
Identification, diagnosis and treatment of heart failure: could we do better?A D StruthersJournal of Cardiac Failure|March 1, 1996
Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failureA D StruthersPageof 25